Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

http://www.wikidata.org/entity/Q35842626

about

Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation The emerging role of biotechnological drugs in the treatment of gout Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells Rationale of using different biological therapies in rheumatoid arthritis.Suppression of ongoing experimental arthritis by a chinese herbal formula (huo-luo-xiao-ling dan) involves changes in antigen-induced immunological and biochemical mediators of inflammation.Translational systems biology of inflammation: potential applications to personalized medicine.The inflammatory response to cell death.IL-1β and IL-18: inflammatory markers or mediators of hypertension?Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 InforMatrix: treatment of rheumatoid arthritis using biologicals.Use of biologics in rheumatoid arthritis: current and emerging paradigms of care.Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.The sterile inflammatory response.Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.Biomaterial strategies for generating therapeutic immune responses.Anti-Inflammatory and Antinociceptive Activities of a Hydroethanolic Extract of Tamarindus indica Leaves.IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro.Effects of cichoric acid extract from Echinacea purpurea on collagen-induced arthritis in rats.A high molecular weight protein extract of Mastobranchus indicus (Mi-64) having antiarthritic activity in experimental animals.Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist.Evaluation of anti-inflammatory potential of the ethanolic extract of the Saussurea lappa root (costus) on adjuvant-induced monoarthritis in rats.Effect of fucoxanthin alone and in combination with D-glucosamine hydrochloride on carrageenan/kaolin-induced experimental arthritis in rats.

P2860

Q26823386-E384D03E-3658-469A-861E-12CB1F7CB94B Q26825459-E3C84DA6-4A36-4A8D-BD3F-0E126BCD4B5F Q28218493-8CAA403D-1DA0-42E9-94E5-F41B21437A74 Q30413598-B9820D4D-6F06-40F1-88F2-74AEB4895BBA Q33639413-0F6D70F1-6480-4BE4-9E5B-13251359D556 Q34011616-E80EEEBE-F38C-4C0D-AA9E-166C13977AE3 Q34153073-F8491C72-7746-4641-ACB2-BBD476A4DAE0 Q34219054-54B623EB-08B2-4811-A724-B52ABB2B7BB6 Q34585279-B79A86F2-E0E7-4D39-8534-1DF21B559FA4 Q34718276-A8449228-81D7-4343-BDA4-D4621B2643E0 Q34914125-8DF3CD03-47D9-42D4-9DDE-0DA370A60C62 Q35638252-D963EC1B-25AC-447F-83FD-3D9824FA741F Q35846222-453EE549-7FEA-424B-B39A-065D99480FDA Q36171750-EA189FC8-9DC7-4383-838C-D7201B565332 Q36573901-014CF35E-0513-4C18-A8BA-CCC9FE83AA91 Q37000165-11E21680-598A-48C6-ACF8-F04CD29BBE38 Q37259317-D641EC42-C0C9-4085-9605-D27097F7A14A Q37716003-A2E8DAB4-5500-452E-9A90-C0ADBBF245A8 Q37786627-2EC98DD2-011C-4E6C-A84F-34E2613336A3 Q39271088-61744FAC-7803-4417-8F7E-1698363E0F50 Q42326601-61A364AC-F924-4B37-9457-D751511F2E6A Q43241239-4F3A4383-BB27-47EE-BD01-03D3558027C1 Q43983228-3BFE8039-5523-4952-83F5-30295448BC56 Q46390747-E39B7625-CA49-47C9-BB49-5232D7EEC604 Q52730350-D5C33FE3-E17C-45DF-A2AB-C5BD7A0C5B5C Q52908848-BCC239B9-EFF7-47FE-8445-06407419F984 Q54439336-43719AF9-8528-4D73-B08E-116993F5A0F3

P2860

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

http://www.wikidata.org/entity/Q35842626

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@ast

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@en

type

label

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@ast

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@en

prefLabel

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@ast

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@en

P1433

Q35842626-8C312944-0FAB-47A5-AA92-F4DD8DDC6BD1

P1476

Q35842626-C03C2D75-89FF-4D87-B22A-285BBB839A39

P2093

Q35842626-30EBA8A0-2C4C-43D2-B543-BC8BAE829335

Q35842626-A9CCAD50-F8FB-45F8-9E74-3633FD2AA037

Q35842626-E8792CC0-35FD-4BF4-ACCE-4B087B34D0CF

P2860

Q35842626-04C90090-083D-49DD-9983-58ADF9F139FC

Q35842626-09EA6AA7-EC23-4705-ADC4-550A4120CE01

Q35842626-108F3F64-A52A-4EB4-B0EF-05A9859CF276

Q35842626-19F34D85-417B-4FA4-96BB-5277E64C932D

Q35842626-206E46E7-2394-413E-A602-9CD526F77649

Q35842626-2B94D76C-61D7-4B91-B852-9F346F8E6398

Q35842626-441FD461-32E9-4CE3-953C-2BBEF827F0FA

Q35842626-5534C379-97FA-4565-BE88-022249C6C5F6

Q35842626-7C2A2A71-A1F5-407E-B851-5AE2D4C002EB

Q35842626-80A4FB4F-32DA-4C25-8300-BEA9511B4DA6

P304

Q35842626-D73EA8FB-E3CD-4D87-99CA-21558C06DAC9

P31

Q35842626-7D195DEE-DD98-4A77-B69E-F30BBB6D9943

P356

Q35842626-995A3877-971B-4DA2-B21F-5DD9EDDC6BD4

P407

Q35842626-7CC11D9B-A2BC-47C0-9E7F-CFD97FB4F6BC

P433

Q35842626-A3DF75ED-E367-4D79-A52D-FA400C9ABC7A

P478

Q35842626-8F8F296D-B173-44E9-BF92-705FB985E2DF

P577

Q35842626-76F3A423-2D53-4EF4-9454-AF8C3EFBFC9D

P698

Q35842626-3287137F-BE68-4C82-9014-F85CBAA3E4E0

P356

14712598.4.8.1333

P1433

Expert Opinion on Biological Therapy

P1476

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

@en

P2093

Imran Iqbal

http://www.w3.org/2001/XMLSchema#string

Richard Stern

http://www.w3.org/2001/XMLSchema#string

Roy Fleischmann

http://www.w3.org/2001/XMLSchema#string

P2860

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Cytokine pathways and joint inflammation in rheumatoid arthritis.

Bone changes in early rheumatoid arthritis.

Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts.

Potential biologic agents for treating rheumatoid arthritis.

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

P304

1333-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.4.8.1333

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15268666

http://www.w3.org/2001/XMLSchema#string